NNC0519-0130
A Research Study Comparing Different Ways of Increasing the Dose of NNC0519-0130 in Participants With Overweight or Obesity
Novo Nordisk · Phase 1 · Completed · Enrollment 134
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Arm 1: NNC0519-0130 | n/r | n/r | n/r | n/r | n/r |
| Arm 2: NNC0519-0130 | n/r | n/r | n/r | n/r | n/r |
| Arm 3: NNC0519-0130 | n/r | n/r | n/r | n/r | n/r |
| Arm 4: NNC0519-0130 | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.